| Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer YL Wu, M Tsuboi, J He, T John, C Grohe, M Majem, JW Goldman, ... New England Journal of Medicine, 2020 | 1361 | 2020 |
| Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally … D Miles, J Gligorov, F André, D Cameron, A Schneeweiss, C Barrios, B Xu, ... Annals of Oncology 32 (8), 994-1004, 2021 | 447 | 2021 |
| Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC AI Masahiro Tsuboi, M.D., Roy S. Herbst, M.D., Ph.D., Thomas John, M.B., B.S ... The new england journal of medicine 4 (389), 137-147, 2023 | 178* | 2023 |
| Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy AB Şahin, E Cubukcu, B Ocak, A Deligonul, S Oyucu Orhan, S Tolunay, ... Scientific Reports 11 (1), 14662, 2021 | 75 | 2021 |
| Medication errors in chemotherapy preparation and administration: a survey conducted among oncology nurses in Turkey A Ulas, K Silay, S Akinci, D Dede, M AKINCI, M ŞENDUR, E Cubukcu, ... Asian Pacific Journal of Cancer Prevention 16 (5), 2015 | 62 | 2015 |
| Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab? A Ulas, N Avci, T Kos, E Cubukcu, OF Olmez, N Bulut, M Degirmenci lung cancer 18, 20, 2015 | 62 | 2015 |
| Aurora A overexpression in breast cancer patients induces taxane resistance and results in worse prognosis Y Cirak, Y Furuncuoglu, O Yapicier, A Aksu, E Cubukcu J buon 20 (6), 1414-9, 2015 | 60 | 2015 |
| Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer N Avci, A Deligonul, S Tolunay, E Cubukcu, O Fatih Olmez, A Ulas, ... J BUON 20 (1), 45-9, 2015 | 35 | 2015 |
| Comparison of three different treatment modalities in the management of cancer cachexia O Kanat, E Cubukcu, N Avci, F Budak, I Ercan, M Canhoroz, F Olmez Tumori Journal 99 (2), 229-233, 2013 | 34 | 2013 |
| Prognostic significance of c-erbB2 overexpression in patients with metastatic gastric cancer M Bayrak, OF Olmez, E Kurt, E Cubukcu, T Evrensel, O Kanat, ... Clinical and Translational Oncology 15, 307-312, 2013 | 31 | 2013 |
| Türkiye’de meme kanserli hastaların tanı ve tedavi yöntemlerine ulaşım hızı; çok merkezli gözlemsel çalışma P Saip, S Keskin, M Özkan, MA Kaplan, F Aydoğan, GG Demirağ, ... The Journal of Breast Health 7 (3), 109-117, 2011 | 27 | 2011 |
| The immunohistochemical expression of c-Met is an independent predictor of survival in patients with glioblastoma multiforme OF Olmez, E Cubukcu, T Evrensel, M Kurt, N Avci, S Tolunay, A Bekar, ... Clinical and Translational Oncology 16, 173-177, 2014 | 26 | 2014 |
| Primary small cell carcinoma of the breast: report of seven cases and review of the literature O Kanat, S Kilickap, T Korkmaz, BBU Oven, M Canhoroz, E Cubukcu, ... Tumori Journal 97 (4), 473-478, 2011 | 25 | 2011 |
| Prognostic significance of estrogen receptor, progesterone receptor, HER2/neu, Ki-67, and nm23 expression in patients with invasive breast cancer E Cubukcu, O Kanat, O Fatih Olmez, S Kabul, M Canhoroz, N Avci, ... J BUON 18 (2), 359-65, 2013 | 23 | 2013 |
| Biological subtypes and distant relapse pattern in breast cancer patients after curative surgery (Study of Anatolian Society of Medical Oncology) MA Kaplan, UY Arslan, A Işıkdogan, F Dane, B Oksuzoglu, M Inanc, ... Breast Care 11 (4), 248-252, 2016 | 21 | 2016 |
| Clinicopathologic features and genetic characteristics of the BRCA1/2 mutation in Turkish breast cancer patients G Cecener, LS Takanlou, MS Takanlou, U Egeli, GG Eskiler, S Aksoy, ... Cancer genetics 240, 23-32, 2020 | 17 | 2020 |
| XRCC1 Gene Polymorphisms and Risk of Lung Cancer in Turkish Patients M Karkucak, T Yakut, T Evrensel, A Deligonul, T Gulten, G Ocakoglu, ... International Journal of Human Genetics 12 (2), 113-117, 2012 | 17 | 2012 |
| Somatostatin receptor 2 and 5 expressions in gastroenteropancreatic neuroendocrine tumors in Turkey O Yerci, I Sehitoglu, N Ugras, E Cubukcu, S Yuce, R Bedir, E Cure Asian Pacific Journal of Cancer Prevention 16 (10), 4377-4381, 2015 | 16 | 2015 |
| Prognostic impact of tumor lymphocytic infiltrates in patients with breast cancer undergoing neoadjuvant chemotherapy N Avcı, A Deligönül, S Tolunay, E Cubukcu, ÖF Ölmez, Ö Altmışdörtoğlu, ... Journal of BU ON., 2015 | 14 | 2015 |
| Patients with HER2-positive early breast cancer receiving adjuvant trastuzumab: clinicopathological features, efficacy, and factors affecting survival A Ulas, T Kos, N Avci, E Cubukcu, OF Olmez, N Bulut, M Degirmenci Asian Pacific Journal of Cancer Prevention 16 (4), 1643-1649, 2015 | 14 | 2015 |
Türkkan EvrenselProf of Medical Oncology Uludag UniversityVerified email at uludag.edu.tr
